논문 목록
Issue Date Title Journals
2021-07 Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study DIGESTIVE DISEASES AND SCIENCES
2021-07 Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease LIVER INTERNATIONAL
2021-06 Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models CELL DEATH & DISEASE
2021-06 Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021-06 Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2021-06 External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals JOURNAL OF VIRAL HEPATITIS
2021-05 Hepatitis B Core-Related Antigen: From Virology to Clinical Application SEMINARS IN LIVER DISEASE
2021-05 Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021-05 Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma GUT AND LIVER
2021-05 The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B Journal of Hepatocellular Carcinoma
2021-04 Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial Clinical and molecular hepatology
2021-04 Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021-04 Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients JOURNAL OF KOREAN MEDICAL SCIENCE
2021-04 Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B Clinical and molecular hepatology
2021-04 Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B HEPATOLOGY RESEARCH
2021-03 Artificial intelligence in liver disease JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021-03 A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer Journal of liver cancer (대한간암학회지)
2021-03 Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma CANCER INVESTIGATION
2021-02 Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression Clinical and Translational Gastroenterology
2021-02 Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization Current Oncology
2021-02 Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B EUROPEAN JOURNAL OF INTERNAL MEDICINE
2021-01 Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years JOURNAL OF DIABETES AND ITS COMPLICATIONS
2021-01 Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021-01 Hepatitis B Virus Cure: Targets and Future Therapies International Journal of Molecular Sciences
2021-01 Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study Clinical and molecular hepatology
2021-01 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance Clinical and Translational Gastroenterology
2021-01 Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy GUT AND LIVER
2021-01 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2021-01 Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir JOURNAL OF VIRAL HEPATITIS
2020-12 A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy JOURNAL OF VIRAL HEPATITIS
2020-12 Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2020-12 Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion Journal of hepatocellular carcinoma
2020-12 Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020-12 Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study GUT
2020-11 Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study KOREAN JOURNAL OF INTERNAL MEDICINE
2020-11 The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization GUT AND LIVER
2020-11 Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals Cancers
2020-11 High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis JOURNAL OF VIRAL HEPATITIS
2020-11 Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B DIGESTIVE AND LIVER DISEASE
2020-09 Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack CEREBROVASCULAR DISEASES
2020-09 Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) HEPATOLOGY INTERNATIONAL
2020-09 Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2020-09 Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus GUT AND LIVER
2020-09 Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma JOURNAL OF VIRAL HEPATITIS
2020-09 Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation Cancers
2020-08 Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial AMERICAN JOURNAL OF GASTROENTEROLOGY
2020-08 Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement LANCET GASTROENTEROLOGY & HEPATOLOGY
2020-07 A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement JOURNAL OF HEPATOLOGY
2020-07 An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia LIVER INTERNATIONAL
2020-07 RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection HEPATOLOGY
2020-07 Entecavir plus tenofovir vs. lamivudine/telbivudine plus adefovir in chronic hepatitis B patients with prior suboptimal response Clinical and molecular hepatology
2020-07 IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses JOURNAL OF HEPATOLOGY
2020-07 Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study GUT AND LIVER
2020-07 Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020-06 How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease? JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2020-06 Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020-05 Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C GUT AND LIVER
2020-05 Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study LANCET GASTROENTEROLOGY & HEPATOLOGY
2020-05 Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B JOURNAL OF KOREAN MEDICAL SCIENCE
2020-05 Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib forAdvanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020-04 A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea PLOS ONE
2020-04 Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk AMERICAN JOURNAL OF GASTROENTEROLOGY
2020-03 Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020-03 Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase Clinical and Translational Gastroenterology
2020-03 An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate JOURNAL OF VIRAL HEPATITIS
2020-03 Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2020-02 HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines JOURNAL OF CANCER
2020-01 A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea Clinical and molecular hepatology
2020-01 Hepatocellular carcinoma risk steadily persists over time despite long-term antiviral therapy for hepatitis B: A multicenter study CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
2020-01 Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection Clinical and molecular hepatology
2020-01 Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study MODERN RHEUMATOLOGY
2020-01 Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2019-12 Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy SCIENTIFIC REPORTS
2019-12 Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis DIGESTIVE DISEASES AND SCIENCES
2019-12 Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B Clinical and molecular hepatology
2019-12 Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2019-12 Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2019-11 The remaining challenges of HCV treatment in the direct-acting antivirals era JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2019-10 Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
2019-09 Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir Clinical and molecular hepatology
2019-09 External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy LIVER INTERNATIONAL
2019-09 Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation CANCER MEDICINE
2019-09 A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea JOURNAL OF HEPATOLOGY
2019-08 Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells JOURNAL OF HEPATOLOGY
2019-08 Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
2019-08 Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2019-07 Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis GASTROENTEROLOGY
2019-06 Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2019-06 Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea ANNALS OF SURGICAL TREATMENT AND RESEARCH